Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01628159 · ClinicalTrials.gov registry record · NA
LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 657
- Enrollment target
NCT01628159: Completed NA study, sponsored by C. R. Bard.
NCT01628159 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 657 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01628159, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 657 participants
- Enrollment target
Study Summary
The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries.
Interventions
- DEVICE Lutonix Drug Coated Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT01628159 record still lists
NCT01628159 is an interventional study that assigns participants to a tested intervention. The registered 657 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Lutonix Drug Coated Balloon is the first listed.
NCT01628159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01628159 about?
NCT01628159 is a clinical study titled "LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)". The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries.
What is the current status of trial NCT01628159?
This trial is currently completed. It is a NA study. The enrollment target is 657 participants. The study started on 2012-06. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01628159?
The interventions under investigation include: Lutonix Drug Coated Balloon (DEVICE).
Who is sponsoring clinical trial NCT01628159?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01628159's enrollment target sits among peer trials
657 156th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03671044 · 657 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
- NCT05338697 · 657 participants
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia